Bryant R. England

6.7k total citations · 1 hit paper
129 papers, 2.8k citations indexed

About

Bryant R. England is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Bryant R. England has authored 129 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Rheumatology, 43 papers in Pulmonary and Respiratory Medicine and 28 papers in Epidemiology. Recurrent topics in Bryant R. England's work include Rheumatoid Arthritis Research and Therapies (74 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (40 papers) and Systemic Lupus Erythematosus Research (26 papers). Bryant R. England is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (74 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (40 papers) and Systemic Lupus Erythematosus Research (26 papers). Bryant R. England collaborates with scholars based in United States, United Kingdom and Lebanon. Bryant R. England's co-authors include Ted R. Mikuls, Geoffrey M. Thiele, Kaleb Michaud, Daniel R. Anderson, Harlan Sayles, Joshua F. Baker, Brian C. Sauer, Grant W. Cannon, Punyasha Roul and Michael Karsy and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and CHEST Journal.

In The Last Decade

Bryant R. England

121 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications

2018 359 citations Bryant R. England, Geoffrey M. Thiele et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bryant R. England United States	27	1.5k	664	392	389	388	129	2.8k
Elena Myasoedova United States	25	2.4k 1.6×	428 0.6×	371 0.9×	448 1.2×	223 0.6×	102	3.5k
Yoon‐Kyoung Sung South Korea	30	1.6k 1.1×	229 0.3×	425 1.1×	609 1.6×	236 0.6×	221	3.3k
Elizabeth V. Arkema Sweden	30	1.3k 0.9×	998 1.5×	534 1.4×	691 1.8×	1.2k 3.0×	103	3.2k
Lorenzo Cavagna Italy	28	727 0.5×	671 1.0×	585 1.5×	410 1.1×	230 0.6×	119	2.2k
José Luís Callejas-Rubio Spain	27	1.0k 0.7×	426 0.6×	276 0.7×	722 1.9×	248 0.6×	143	2.2k
A. H. Zwinderman Netherlands	26	1.8k 1.2×	832 1.3×	307 0.8×	581 1.5×	1.1k 2.9×	48	4.0k
Andrew J.K. Östör United Kingdom	31	1.9k 1.3×	375 0.6×	607 1.5×	982 2.5×	242 0.6×	131	3.8k
Liron Caplan United States	36	2.7k 1.8×	445 0.7×	612 1.6×	749 1.9×	305 0.8×	100	4.5k
Dörte Huscher Germany	38	1.5k 1.0×	1.5k 2.3×	566 1.4×	872 2.2×	321 0.8×	137	4.4k
Carlo Alberto Scirè Italy	32	2.1k 1.4×	245 0.4×	245 0.6×	477 1.2×	138 0.4×	137	3.1k

Countries citing papers authored by Bryant R. England

Since Specialization

Citations

This map shows the geographic impact of Bryant R. England's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryant R. England with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryant R. England more than expected).

Fields of papers citing papers by Bryant R. England

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryant R. England. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryant R. England. The network helps show where Bryant R. England may publish in the future.

Co-authorship network of co-authors of Bryant R. England

This figure shows the co-authorship network connecting the top 25 collaborators of Bryant R. England. A scholar is included among the top collaborators of Bryant R. England based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryant R. England. Bryant R. England is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

England, Bryant R., Joshua F. Baker, Michael George, et al.. (2025). Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort study. The Lancet Rheumatology. 7(3). e166–e177. 4 indexed citations

Wichman, Christopher, Jianghu Dong, Punyasha Roul, et al.. (2025). Non-TNFi biologic and targeted synthetic DMARDs in rheumatoid arthritis-associated interstitial lung disease: A propensity score-matched, active-comparator, new-user study. Seminars in Arthritis and Rheumatism. 73. 152735–152735. 3 indexed citations

England, Bryant R.. (2024). Rheumatoid arthritis-associated interstitial lung disease: Advancing the identification and management. Seminars in Arthritis and Rheumatism. 70. 152578–152578. 1 indexed citations

Mikuls, Ted R., Joshua F. Baker, Grant W. Cannon, et al.. (2024). The Veterans Affairs Rheumatoid Arthritis Registry: A unique population in rheumatoid arthritis research. Seminars in Arthritis and Rheumatism. 70. 152580–152580.

Androsenko, Maria, Bridget Kramer, Mary T. Brophy, et al.. (2024). Comparison of Gout Flares With the Initiation of Treat‐to‐Target Allopurinol and Febuxostat: A Post‐Hoc Analysis of a Randomized Multicenter Trial. Arthritis & Rheumatology. 76(10). 1552–1559. 1 indexed citations

Baraff, Aaron, Katherine D. Wysham, David Liew, et al.. (2024). Escalation to Biologics After Methotrexate Among US Veterans With Rheumatoid Arthritis Grouped by Rural Versus Urban Areas. Arthritis Care & Research. 77(1). 23–29.

Klein, Jacob, Joshua F. Baker, Yangyuna Yang, et al.. (2024). MUC5B promoter variant and survival in rheumatoid arthritis-associated interstitial lung disease. Lara D. Veeken. 64(SI). SI47–SI54. 1 indexed citations

Poole, Jill A., Aaron Schwab, Geoffrey M. Thiele, et al.. (2024). Unique transcriptomic profile of peripheral blood monocytes in rheumatoid arthritis-associated interstitial lung disease. Lara D. Veeken. 64(SI). SI37–SI46. 2 indexed citations

Roul, Punyasha, Yangyuna Yang, Tate Johnson, et al.. (2023). Multimorbidity Patterns and Rheumatoid Arthritis Disease Outcomes: Findings From a Multicenter, Prospective Cohort. Arthritis Care & Research. 77(3). 337–348. 7 indexed citations

10.

Roul, Punyasha, Yangyuna Yang, Grant W. Cannon, et al.. (2023). Updating and Validating the Rheumatic Disease Comorbidity Index to Incorporate ICD‐10‐CM Diagnostic Codes. Arthritis Care & Research. 75(10). 2199–2206. 3 indexed citations

11.

Schmidt, Cynthia, Jill A. Poole, Dana P. Ascherman, et al.. (2023). Peripheral Blood Biomarkers for Rheumatoid Arthritis–Associated Interstitial Lung Disease: A Systematic Review. ACR Open Rheumatology. 5(4). 201–226. 15 indexed citations

12.

England, Bryant R., Punyasha Roul, Yangyuna Yang, et al.. (2023). Extracting forced vital capacity from the electronic health record through natural language processing in rheumatoid arthritis‐associated interstitial lung disease. Pharmacoepidemiology and Drug Safety. 33(1). e5744–e5744. 9 indexed citations

13.

Singh, Namrata, Laura S. Gold, Jiha Lee, et al.. (2023). Frailty and Risk of Serious Infections in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted‐Synthetic Disease‐Modifying Antirheumatic Drugs. Arthritis Care & Research. 76(5). 627–635. 6 indexed citations

14.

England, Bryant R., Punyasha Roul, Harlan Sayles, et al.. (2022). Cause‐Specific Mortality in Patients With Gout in the US Veterans Health Administration: A Matched Cohort Study. Arthritis Care & Research. 75(4). 808–816. 7 indexed citations

15.

Mikuls, Ted R., Rohit Gaurav, Geoffrey M. Thiele, et al.. (2021). The impact of airborne endotoxin exposure on rheumatoid arthritis-related joint damage, autoantigen expression, autoimmunity, and lung disease. International Immunopharmacology. 100. 108069–108069. 21 indexed citations

16.

Özen, Gülşen, Sofia Pedro, Bryant R. England, et al.. (2019). Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease‐Modifying Antirheumatic Drugs. ACR Open Rheumatology. 1(7). 424–432. 45 indexed citations

17.

England, Bryant R., Punyasha Roul, Tina Mahajan, et al.. (2019). Performance of Administrative Algorithms to Identify Interstitial Lung Disease in Rheumatoid Arthritis. Arthritis Care & Research. 72(10). 1392–1403. 29 indexed citations

18.

Johnson, Tate, Ted R. Mikuls, & Bryant R. England. (2019). Assessment of cardiovascular disease risk in rheumatoid arthritis. 26(1). 41–47. 1 indexed citations

19.

England, Bryant R., Michael J. Duryee, Punyasha Roul, et al.. (2019). Malondialdehyde–Acetaldehyde Adducts and Antibody Responses in Rheumatoid Arthritis–Associated Interstitial Lung Disease. Arthritis & Rheumatology. 71(9). 1483–1493. 60 indexed citations

20.

England, Bryant R., Geoffrey M. Thiele, & Ted R. Mikuls. (2016). Anticitrullinated protein antibodies: origin and role in the pathogenesis of rheumatoid arthritis. Current Opinion in Rheumatology. 29(1). 57–64. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact